[Agranulocytosis during propylthiouracil therapy; case report]. 1954

R K THORSEN

UI MeSH Term Description Entries
D011441 Propylthiouracil A thiourea antithyroid agent. Propythiouracil inhibits the synthesis of thyroxine and inhibits the peripheral conversion of throxine to tri-iodothyronine. It is used in the treatment of hyperthyroidism. (From Martindale, The Extra Pharmacopeoia, 30th ed, p534) 6-Propyl-2-Thiouracil,6 Propyl 2 Thiouracil
D000380 Agranulocytosis A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS). Granulocytopenia,Agranulocytoses,Granulocytopenias
D013889 Thiouracil Occurs in seeds of Brassica and Crucifera species. Thiouracil has been used as antithyroid, coronary vasodilator, and in congestive heart failure although its use has been largely supplanted by other drugs. It is known to cause blood dyscrasias and suspected of terato- and carcinogenesis.

Related Publications

R K THORSEN
March 1949, Journal of the American Medical Association,
R K THORSEN
July 1948, The American journal of medicine,
R K THORSEN
October 1979, Annals of internal medicine,
R K THORSEN
December 1965, The Indian practitioner,
R K THORSEN
November 1988, The British journal of clinical practice,
R K THORSEN
August 1957, Virginia medical monthly,
R K THORSEN
April 1959, Texas state journal of medicine,
R K THORSEN
January 1951, Journal of the American Medical Association,
R K THORSEN
January 1950, Annals of internal medicine,
Copied contents to your clipboard!